Phase I trial of M<sub>2</sub>ES, a novel polyethylene glycosylated recombinant human endostatin, plus gemcitabine in advanced pancreatic cancer.
第一作者:
Yang,Chen
第一单位:
National Engineering Laboratory for Antitumor Protein Therapeutics, School of Life Sciences, Tsinghua University, Beijing 100084, P.R. China ; Beijing Key Laboratory of Protein Therapeutics, School of Life Sciences, Tsinghua University, Beijing 100084, P.R. China ; Cancer Biology Laboratory, School of Life Sciences, Tsinghua University, Beijing 100084, P.R. China.
作者:
DOI
10.3892/mco.2014.271
PMID
24940500
发布时间
2021-10-21
- 浏览36
Molecular and clinical oncology
2014年2卷4期
586-590页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



